We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

CA125 Levels and Other Inflammatory Markers in Laparoscopic Ventral Hernia Repair

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01323361
First Posted: March 25, 2011
Last Update Posted: January 28, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Sykehuset Innlandet HF
Information provided by (Responsible Party):
Jan Lambrecht, Oslo University Hospital
March 24, 2011
March 25, 2011
January 28, 2013
April 2011
August 2012   (Final data collection date for primary outcome measure)
Level of variation in inflammatory markers related to "trauma" impact [ Time Frame: 6 weeks post surgery ]
Same as current
Complete list of historical versions of study NCT01323361 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
CA125 Levels and Other Inflammatory Markers in Laparoscopic Ventral Hernia Repair
Multi-centre Observational Pilot-study for Evaluation of Variation in CA-125 and Other Inflammatory Markers in the Perioperative Period of Laparoscopic Ventral Hernia Repair
The study aims to show variation in CA-125 and other inflammatory markers assumed to be a response to trauma and peritoneal inflammation in the perioperative period of laparoscopic ventral hernia repair
CA-125 and other inflammatory markers as body temperature, CRP, PCT, leucocytes and neutrophils measured pre- and post-operatively - correlated to trauma size i.e. area of dissection, mesh size, number of fixation points etc.
Interventional
Not Provided
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Basic Science
Hernia
Procedure: Laparoscopic ventral hernia repair
Patients operated with laparoscopic repair of ventral or incisional hernia
No Intervention: Non-immunosupressed
Normal population
Intervention: Procedure: Laparoscopic ventral hernia repair
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
10
August 2012
August 2012   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Adults admitted for ventral or incisional hernia repair

Exclusion Criteria:

  • Loss-of-domain
  • ASA above III
  • Liver failure
  • Abnormal CA-125 prior to surgery
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Norway
 
 
NCT01323361
2010/3264-1 (REK)
2010/29472 ( Other Identifier: Datainspectorate, Norway )
No
Not Provided
Not Provided
Jan Lambrecht, Oslo University Hospital
Oslo University Hospital
Sykehuset Innlandet HF
Study Director: jan r lambrecht, md Sykehuset Innlandet HF
Study Chair: ole m øyen, Dr. Med. Oslo University Hospital
Study Chair: erik trondsen, Dr. Med. Oslo University Hospital
Oslo University Hospital
January 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP